Iberdomide or CC-220 (CELMoD®)
Information provided by www.dynamed.com
and
www.uptodate.com
Get the latest thought leadership on your T-Cell Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.